Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma

por Pan, Minggui, Trieu, Maily K., Sidhu, Manpreet, Yu, Jeanette, Seto, Tiffany, Ganjoo, Kristen
Publicado 2021